Improving Sexual Health among Adolescents and Young Adults
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 02/28/2024
Resource from the RWHAP Best Practices Compilation updated on 01/08/2024
Resource from the RWHAP Best Practices Compilation updated on 01/12/2024
Resource from the RWHAP Best Practices Compilation updated on 02/28/2024
Resource from the RWHAP Best Practices Compilation updated on 05/07/2024
Resource updated 05/15/2024
Resource from the RWHAP Best Practices Compilation updated on 04/08/2024
Resource from the RWHAP Best Practices Compilation updated on 06/18/2024
Blog updated 08/31/2023
Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
Resource from the RWHAP Best Practices Compilation updated on 12/15/2023
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Activities of jurisdictions and their partner clinics to implement Hepatitis C Virus (HCV) Data to Care project activities, based on their previous experience, data management infrastructure, ability to share data, and staffing resources.
The implementation manual summarizes approaches, lessons learned, and best practices for supporting the replication of efforts, and lists key resources for health department jurisdictions to start implementation.
Resource updated 05/15/2024
Planning and implementation steps when using a Pharmacy Benefit Manager (PBM) to administer an AIDS Drug Assistance Program (ADAP).
Resource updated 09/19/2023
Resource updated 05/29/2024
Resource from the RWHAP Best Practices Compilation updated on 03/18/2024
Resource from the RWHAP Best Practices Compilation updated on 03/18/2024
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024